147 related articles for article (PubMed ID: 32016672)
1. Outcomes for a Large Cohort of Patients with Rectal Neuroendocrine Tumors: an Analysis of the National Cancer Database.
Zhao B; Hollandsworth HM; Lopez NE; Parry LA; Abbadessa B; Cosman BC; Ramamoorthy SL; Eisenstein S
J Gastrointest Surg; 2021 Feb; 25(2):484-491. PubMed ID: 32016672
[TBL] [Abstract][Full Text] [Related]
2. Size Criteria Is Not Sufficient in Selecting Patients for Local Excision Versus Radical Excision for Rectal Neuroendocrine Tumors >2 cm: A National Cancer Database Analysis.
Izquierdo KM; Humphries MD; Farkas LM
Dis Colon Rectum; 2021 Apr; 64(4):399-408. PubMed ID: 33651006
[TBL] [Abstract][Full Text] [Related]
3. Local Excision Versus Radical Resection for 1- to 2-cm Neuroendocrine Tumors of the Rectum: A National Cancer Database Analysis.
Fields AC; Saadat LV; Scully RE; Davids JS; Goldberg JE; Bleday R; Melnitchouk N
Dis Colon Rectum; 2019 Apr; 62(4):417-421. PubMed ID: 30394988
[TBL] [Abstract][Full Text] [Related]
4. Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
Chen Q; Chen J; Huang Z; Zhao H; Cai J
Eur J Surg Oncol; 2022 Apr; 48(4):864-872. PubMed ID: 34753616
[TBL] [Abstract][Full Text] [Related]
5. Local excision versus radical resection in patients with rectal neuroendocrine tumours: a propensity score match analysis.
Zhao B; Hollandsworth HM; Lopez NE; Parry LA; Abbadessa B; Cosman BC; Ramamoorthy SL; Eisenstein S
ANZ J Surg; 2020 Dec; 90(12):E154-E162. PubMed ID: 32808432
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
[TBL] [Abstract][Full Text] [Related]
7. Local excision results in comparable survival to radical resection for early-stage rectal carcinoid.
Ezekian B; Adam MA; Turner MC; Gilmore BF; Freischlag K; Leraas HJ; Mantyh CR; Migaly J
J Surg Res; 2018 Oct; 230():28-33. PubMed ID: 30100036
[TBL] [Abstract][Full Text] [Related]
8. Short- and Long-term Outcomes of Laparoscopic Total Mesenteric Excision for Neuroendocrine Tumors of the Rectum.
Takatsu Y; Fukunaga Y; Nagasaki T; Akiyoshi T; Konishi T; Fujimoto Y; Nagayama S; Ueno M
Dis Colon Rectum; 2017 Mar; 60(3):284-289. PubMed ID: 28177990
[TBL] [Abstract][Full Text] [Related]
9. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.
Chi Y; Du F; Zhao H; Wang JW; Cai JQ
World J Gastroenterol; 2014 Nov; 20(43):16252-7. PubMed ID: 25473180
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.
Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK
JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112
[TBL] [Abstract][Full Text] [Related]
12. New lymph node staging for rectal neuroendocrine tumors.
Fields AC; McCarty JC; Ma-Pak L; Lu P; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N
J Surg Oncol; 2019 Jan; 119(1):156-162. PubMed ID: 30481376
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Metastases in Rectal Neuroendocrine Tumors: Results of a National Cohort Study.
Concors SJ; Sinnamon AJ; Folkert IW; Mahmoud NN; Fraker DL; Paulson EC; Roses RE
Dis Colon Rectum; 2018 Dec; 61(12):1372-1379. PubMed ID: 30312223
[TBL] [Abstract][Full Text] [Related]
14. When is neoadjuvant chemotherapy indicated in rectal neuroendocrine tumors? An analysis of the National Cancer Database.
Gefen R; Emile SH; Horesh N; Garoufalia Z; Freund MR; Wexner SD
Tech Coloproctol; 2024 May; 28(1):56. PubMed ID: 38772962
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors.
Ngamruengphong S; Kamal A; Akshintala V; Hajiyeva G; Hanada Y; Chen YI; Sanaei O; Fluxa D; Haito Chavez Y; Kumbhari V; Singh VK; Lennon AM; Canto MI; Khashab MA
Gastrointest Endosc; 2019 Mar; 89(3):602-606. PubMed ID: 30447216
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of radical surgical treatment in the management of 58 locally advanced rectal neuroendocrine neoplasms, one multicenter retrospective study.
Wang Z; Liu Z; Wen Z; Li R; An K; Mei S; Chen J; Shen H; Li J; Zhao F; Wei F; Xiao T; Liu Q
Eur J Surg Oncol; 2021 Dec; 47(12):3166-3174. PubMed ID: 34294465
[TBL] [Abstract][Full Text] [Related]
17. Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors.
Chen WJ; Wu N; Zhou JL; Lin GL; Qiu HZ
World J Gastroenterol; 2015 Aug; 21(30):9142-9. PubMed ID: 26290641
[TBL] [Abstract][Full Text] [Related]
18. A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Russell MC; Cardona K; Sullivan PS; Maithel SK
J Surg Oncol; 2019 Nov; 120(6):932-939. PubMed ID: 31448820
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic analysis of colon and rectal neuroendocrine neoplasm in different stages].
Huang YT; Jia R; Xu Q; Ji SJ; Cui HT; Xu JM
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):146-151. PubMed ID: 30862146
[No Abstract] [Full Text] [Related]
20. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors.
Sharpe SM; In H; Winchester DJ; Talamonti MS; Baker MS
J Gastrointest Surg; 2015 Jan; 19(1):117-23; discussion 123. PubMed ID: 25155459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
